Predication the Suppressing Human Oral Cancer Cell Line by Curcumin through the Research of Fas Receptor

Abstract —Curcumin is commonly applied as food coloring and seasoning but recent research show that curcumin is able to enhance the activation of Fas receptor to the cancer cell apoptosis through extrinsic pathway. Oral cancer results from the particular habit of chewing betel nuts that Taiwanese have. The additive in betel nuts (such as lime) is the main reason that increase the cancer rate of people chewing betel nuts and further increase the death rate gradually. The major treatments for oral cancer are still chemotherapy and surgery. This research expects to perform the computer simulation to calculate the activity of curcumin to oral cancer as medicine. The pharmaceutical activity are evaluate by the score from docking procedure perform by simulation program. We hope this experiment can be the evidence that curcumin can practically be used as medicine for oral cancer therapy in future. Keywords- curcumin; Fas receptor; cell apoptosis; oral cancer; Oral cancer is adocking

[1]  G Ruberti,et al.  Soluble Fas/Apo-1 splicing variants and apoptosis. , 1996, Frontiers in bioscience : a journal and virtual library.

[2]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[3]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[4]  C. Venkatachalam,et al.  LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. , 2003, Journal of molecular graphics & modelling.

[5]  Li Li,et al.  RDOCK: Refinement of rigid‐body protein docking predictions , 2003, Proteins.

[6]  A. Sali,et al.  Alignment of protein sequences by their profiles , 2004, Protein science : a publication of the Protein Society.

[7]  C. Venkatachalam,et al.  LigScore: a novel scoring function for predicting binding affinities. , 2005, Journal of molecular graphics & modelling.

[8]  Shishir Shishodia,et al.  Molecular targets of dietary agents for prevention and therapy of cancer. , 2006, Biochemical pharmacology.

[9]  Myung-Suk Kim,et al.  Curcumin Inhibits Hypoxia-Inducible Factor-1 by Degrading Aryl Hydrocarbon Receptor Nuclear Translocator: A Mechanism of Tumor Growth Inhibition , 2006, Molecular Pharmacology.

[10]  S. Bhattacharyya,et al.  Tumor-Induced Oxidative Stress Perturbs Nuclear Factor-κB Activity-Augmenting Tumor Necrosis Factor-α–Mediated T-Cell Death: Protection by Curcumin , 2007 .

[11]  Jen-kun Lin Molecular targets of curcumin. , 2007, Advances in experimental medicine and biology.

[12]  S. Bhattacharyya,et al.  Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. , 2007, Cancer research.

[13]  Johannes Kirchmair,et al.  CAESAR: A New Conformer Generation Algorithm Based on Recursive Buildup and Local Rotational Symmetry Consideration. , 2007 .

[14]  Eugene N. Myers Oral Cancer: Diagnosis, Management, and Rehabilitation , 2008 .

[15]  M. Fan,et al.  Curcumin induces apoptosis through FAS and FADD, in caspase-3-dependent and -independent pathways in the N18 mouse-rat hybrid retina ganglion cells. , 2009, Oncology reports.

[16]  Roland Eils,et al.  Dynamics within the CD95 death-inducing signaling complex decide life and death of cells , 2010, Molecular systems biology.